|
|
||||||||
From the
1 From The Franklin McLean Memorial Research Institute and the Department of Biochemistry, University of Chicago, Chicago, Illinois 60637
Erythropoietin, a glycoprotein that induces normal erythrocyte development, has 16 to 18 sialic acid residues per mole. Desialation results in complete loss of biological activity when it is assayed in vivo. When the assay is done in vitro asialoerythropoietin has full activity, or when assayed at low levels of hormones is about three times more active than the native hormone. The loss of activity can be explained by the hepatic removal of asialoglycoproteins from the circulation (Morell, A. G., Irvine, R. A., Sternlieb, I., Scheinberg, I. H., and Ashwell, G. (1968) J. Biol. Chem. 243, 155). Asialoorosomucoid or stachyose injected into assay animals act as competitors and permit 25 to 35% of the original activity of erythropoietin to be seen in vivo after desialation. Treatment of asialoerythropoietin with galactose oxidase results in recovery of 45% of the original activity, confirming an earlier finding (Lukowsky, W. A., and Painter, R. H. (1972) Can. J. Biochem. 50, 909). Asialoerythropoietin is more sensitive to heat denaturation and trypsin action than the native hormone. Our data indicate that terminal sialic acid is required for chemical and biological stability but not for action on target cells of the bone marrow. The asialohormone has enhanced activity towards the target cells.
On the Mechanism of Erythropoietin-induced Differentiation
XIII. THE ROLE OF SIALIC ACID IN ERYTHROPOIETIN ACTION
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. K. Tee, J.-L. Vigne, J. Yu, and R. N. Taylor Natural and recombinant human glycodelin activate a proapoptotic gene cascade in monocyte cells J. Leukoc. Biol., April 1, 2008; 83(4): 843 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Engert Recombinant human erythropoietin in oncology: current status and further developments Ann. Onc., October 1, 2005; 16(10): 1584 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jayachandran, M. S. Shaila, and A. A. Karande Analysis of the Role of Oligosaccharides in the Apoptotic Activity of Glycodelin A J. Biol. Chem., March 5, 2004; 279(10): 8585 - 8591. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Skibeli, G. Nissen-Lie, and P. Torjesen Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin Blood, December 15, 2001; 98(13): 3626 - 3634. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |